WASHINGTON, Feb. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Feb. 18, 2025, from the Biotechnology Innovation Organization: * * * To: U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Re: Docket No. FDA-2024-D-4311; Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products * * * The Biotechnology Innovation Organization (BIO) thanks the  more